| MACULOPATHIE ET AUTRES ANOMALIES | |||||||||
| NON ANALYSABLE | NORMAL | OEDEME | MLA | AUTRE MACULOPATHIE | AUTRE RETINOPATHIE | TOTAL | |||
| OD | 11 | 58 | 1 | 5 | 3 | 3 | 81 | ||
| OG | 14 | 56 | 1 | 4 | 1 | 5 | 81 | ||
| OD + OG | 25 | 114 | 2 | 9 | 4 | 8 | 162 | ||
| N/A | NORMAL | OEDEME | MLA | AUTRE MACULOPATHIE | AUTRE RETINOPATHIE | ||||
| OD | 13,58% | 71,60% | 1,23% | 6,17% | 3,70% | 3,70% | 100,00% | ||
| OG | 17,28% | 69,14% | 1,23% | 4,94% | 1,23% | 6,17% | 100,00% | ||
| MOYENNE | 15,43% | 70,37% | 1,23% | 5,56% | 2,47% | 4,94% | 100,00% | ||
| NON ANALYSABLE | NORMAL | OEDEME | MLA | AUTRE MACULOPATHIE | AUTRE RETINOPATHIE | TOTAL | |||
| HOMMES | 4 | 40 | 0 | 2 | 3 | 3 | 52 | ||
| 7,69% | 76,92% | 0,00% | 3,85% | 5,77% | 5,77% | 100,00% | |||
| FEMMES | 3 | 19 | 1 | 2 | 1 | 3 | 29 | ||
| 10,34% | 65,52% | 3,45% | 6,90% | 3,45% | 10,34% | 100,00% | |||
| TOTAL | 7 | 59 | 1 | 4 | 4 | 6 | 81 | ||
| 8,64% | 72,84% | 1,23% | 4,94% | 4,94% | 7,41% | 100,00% | |||
|
|
|||||||||
|
|
|||||||||